Pancreatite pós-colangiopancreatografia retrógrada endoscópica: uma revisão narrativa
Post-endoscopic retrograde cholangiopancreatography pancreatitis: narrative literature review
DOI:
https://doi.org/10.34117/bjdv8n11-280Keywords:
colangiopancreatografia retrógrada endoscópica, pancreatite, tor de riscoAbstract
A pancreatite é a complicação mais frequente e, potencialmente, mais agressiva da colangiopancreatografia retrógrada endoscópica (CPRE), resultando em alta morbidade, mortalidade episódica e aumento dos dispêndios com saúde. Nesse sentido, a prevenção da pancreatite pós-CPRE (PPC) segue como um desafio, tornando-se prioridade no meio científico, assim como no meio clínico. O presente artigo contou com o objetivo principal apresentar os estudos publicados sobre pancreatite pós-colangiopancreatografia retrógrada endoscópica, com ênfase nos fatores de risco e preventivos, através de uma revisão narrativa nos bancos de dados PubMed, CAPES, SciELO, BVS e Cochrane Library nos idiomas inglês, espanhol e português com recorte temporal dos últimos 5 anos. Para minimizar a taxa de incidência, perpassa por selecionar o paciente com critérios, estratificar os riscos, além de usar os fármacos para a prevenção, selecionar a melhor técnica e colocar o stent pancreático profilaticamente. Embora nos últimos anos tenha tido progressos nesses setores de pesquisa, ainda persiste uma alta taxa de incidência, podendo variar até 15%. Dessa forma, novas áreas devem ser exploradas com o intuito de mitigar a PPC.
References
AKSHINTALA, V. S. et al. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. v. 6, n. 9, p. 733-742, 2021
BANKS, P. A. et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. v. 62, p. 102-111, 2013.
BHATT, H. Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: An Updated Review of Current Preventive Strategies. Clin Exp Gastroenterol. v. 14, p. 27-32, 2021.
BOAL, C. P. et al. NSAIDs are not enough – a double blinded randomized controlled trial on the impact of intensive hydration for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. European Journal of Gastroenterology & Hepatology. v. 34, n. 7, p. 751-756, 2022.
CHANDRASEKHARA, V. et al. Adverse events associated with ERCP. Gastrointest Endosc. v. 85, n. 1, p. 32-47, 2017.
COTTON, P. B. et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. v. 37, p. 383–393, 1991.
DENG, Z. et al. Prevalence and Factors Associated with Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in Children. Dig Dis Sci. v. 66, n. 1, p. 224-230, 2021.
DUMONCEAU, J. M. et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. v. 52, n. 2 p. 127-149, 2020
ELMUNZER, B. J. Reducing the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis. Digestive Endoscopy. v. 29, n. 7, p. 749-757, 2017.
ELMUNZER, B. J. Preventing Postendoscopic Retrograde Cholangiopancreatography Pancreatitis. Gastrointestinal Endoscopy Clinics Of North America. v. 25, n. 4, p. 725-736, 2015.
FAN, J. H. et al. Updated meta-analysis of pancreatic stent placement in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis. World J Gastroenterol. v. 21, n. 24, p. 7577-83, 2015
FANG, J. et al. Impact of intraduodenal acetic acid infusion on pancreatic duct cannulation during endoscopic retrograde cholangiopancreatography: A double-blind, randomized controlled trial. J Gastroenterol Hepatol. v. 33, n. 10, p. 1804-1810, 2018.
FUNG, B. M. et al. Difficult Biliary Cannulation in Endoscopic Retrograde Cholangiopancreatography: Definitions, Risk Factors, and Implications. Eur Med J Hepatol. v. 9, n. 1, p. 64-72, 2021.
HALTTUNEN, J. et al.. Difficult cannulation as defined by a prospective study of the Scandinavian Association for Digestive Endoscopy (SADE) in 907 ERCPs. Scand J Gastroenterol. v. 49, n. 6, p. 752-8, 2014.
HARSHIL, B. Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: An Updated Review of Current Preventive Strategies. Clin Exp Gastroenterol. v. 14, p. 27-32, 2021.
HAUSER, G. Preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: what can be done?. World Journal Of Gastroenterology. v. 21, n. 4, p. 1069, 2015.
HORMATI, A. et al. Prevalence of Endoscopic Retrograde Cholangiopancreatography Complications and Amylase Sensitivity for Predicting Pancreatitis in ERCP Patients. Gastroenterol Nurs. v. 43, n. 5, p. 350-354, 2020.
IQBAL, U. et al. Post-endoscopic retrograde cholangiopancreatography pancreatitis prevention using topical epinephrine: systematic review and meta-analysis. Endosc Int Open. v. 8, n. 8, p. E1061-E1067, 2020.
JAMRY, A. Risk factors of pancreatitis after endoscopic sphincterotomy. Review of literature and practical remarks based on approximately 10,000 ERCPs. Pol Przegl Chir. v. 89, n. 5, p. 29-33, 2017.
JOHNSON, K. D. et al. Endoscopic Retrograde Cholangiopancreatography-Related Complications and Their Management Strategies: A “Scoping” Literature Review. Dig Dis Sci. v. 65, p. 361–375, 2020.
KOCHAR, B. et al. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endosc. v. 81, p. 143–149, 2015.
LIN, Y. et al. Analysis of risk factors and prevention strategies of post-ERCP pancreatitis. Eur Rev Med Pharmacol v. 21, n. 22, p. 5185-5190, 2017.
MAZAKI, T. el al. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis. J Gastroenterol. v. 49, n. 2 p. 343-55, 2014.
MEQQ, Q. Q. et al. Incidence and risk factors for post-ERCP pancreatitis in pancreas divisum patients without chronic pancreatitis. Scand J Gastroenterol. v. 55, n. 6, p. 732-736, 2020.
MINE, T. et al. Clinical practice guideline for post-ERCP pancreatitis. J Gastroenterol. v. 52 n. 9, p. 1013-1022, 2017.
MOHAMMAD, A. et al. Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis. European Journal of Gastroenterology & Hepatology. v. 29, n. 3, p. 349-354, 2017.
MORALES, S. J. et al.. A Review of Prevention of Post-ERCP Pancreatitis. Gastroenterol Hepatol (N Y). v. 14 n. 5, p. 286-292, 2018.
PAEZ, L. F. et al. Profilaxia da pancreatite pós-colangiopancreatografia retrógrada endoscópica: avaliação de dois regimes com AINEs diferentes. Arq Gastroenterol. v. 58, n. 3, p. 270-275, 2021.
PARK, T. Y. et al. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with rectal non-steroidal anti-inflammatory drugs. Korean J Intern Med. v. 35, n. 3, p. 535-543, 2020.
PEKGOZ, M. Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment. World J Gastroenterol. v. 25, n. 29 p. 4019-4042, 2019.
PHILLIP, V. et al. Identification of risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis in a high volume center. PLOS ONE. v. 16, n. 12, p. e0261576, 2021.
RIBEIRO, I. B. et al. Pancreatitis after endoscopic retrograde cholangiopancreatography: a narrative review. World Journal Of Gastroenterology. v. 27, n. 20, p. 2495-2506, 2021
RYLISKYY, Y; BRYCE G. J. Post-ERCP pancreatitis: Pathophysiology, early identification and risk stratification. Adv Clin Exp Med. v. 27, n. 1, p. 149-154, 2018.
SADEGHI, A. et al. Does melatonin addition to indomethacin decrease post endoscopic retrograde cholangiopancreatography pancreatitis? A randomized double-blind controlled trial. European Journal of Gastroenterology & Hepatology. v. 31, n. 11, p. 1350-1355, 2019.
SHIMAMURA, T. et al. Risk Factors for Post-Endoscopic Retrograde Pancreatography Pancreatitis: A Retrospective Chart Review in a Regional Hospital in Japan. Digestion. v. 101, n. 5, p. 557-562, 2020.
SPEMA, W. C. J. et al. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial. Lancet Gastroenterol Hepatol. v. 6, n. 5, p. 350-358, 2021.
